6533b85dfe1ef96bd12bf1a3
RESEARCH PRODUCT
false
subject
0301 basic medicineChemotherapybiologyColorectal cancerMechanism (biology)business.industrymedicine.medical_treatmentImmunologyImmunotherapymedicine.diseaseImmune checkpoint3. Good healthBlockade03 medical and health sciences030104 developmental biology0302 clinical medicineOncology030220 oncology & carcinogenesisPD-L1medicineCancer researchbiology.proteinImmunology and AllergyCytotoxic T cellbusinessdescription
Background: Chemotherapy is currently evaluated in order to enhance the efficacy of immune checkpoint blockade (ICB) therapy in colorectal cancer. However, the mechanisms by which these drugs could...
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2018-03-15 | OncoImmunology |